A management model for Hospital Hygiene Unit: evidence-based proactive surveillance of potential environmental sources of infection in order to prevent patient's risk.


Journal

Journal of preventive medicine and hygiene
ISSN: 2421-4248
Titre abrégé: J Prev Med Hyg
Pays: Italy
ID NLM: 9214440

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 15 05 2020
accepted: 04 11 2020
entrez: 25 2 2021
pubmed: 26 2 2021
medline: 11 11 2021
Statut: epublish

Résumé

The aim of this study is to describe a proactive surveillance system of food, water and environmental surfaces, in order to avoid Healthcare-Associated Infections (HAIs) from hospital environment. It is a retrospective descriptive study. The surveillance system consists of two integrated phases: pre-analytic and post-analytic. The activities are distinguished in ordinary control activities, performed after scheduled and shared surveys, and compliance activities, performed when it is necessary to establish the adequacy of the destination use, for example opening a new ward. A total of 1,470 Samples were collected and 539 Reports were generated across the five-year study period. Water for human consumption procedure: a statistically significant trend was found only in the total number of Samples collected (p < 0.001). Legionella spp. infection water risk procedure: all Samples and Reports, with the exception of Compliance Report Samples, showed a statistically significant trend (p < 0.001). Pseudomonas aeruginosa water risk procedure: only Ordinary Reports and Compliance Report Samples trend were statistically significant (p = 0.002 and p = 0.028 respectively). Effectiveness of surface sanitization procedure: no trend was statistically significant (p < 0.05). Hospital catering and food surfaces procedure: Samples and Reports yearly number was constant, no trend analysis was performed. HAIs prevalence was never over 5% in the hospital under study. This surveillance system of water, food and environmental surfaces represents an innovative way of approaching hospital safety for patients and personnel because it overcomes the limitations due to a classic approach limited to a laboratory analytic phase only, according to the best available scientific evidence.

Identifiants

pubmed: 33628970
doi: 10.15167/2421-4248/jpmh2020.61.4.1587
pmc: PMC7888400
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

E628-E635

Informations de copyright

©2020 Pacini Editore SRL, Pisa, Italy.

Déclaration de conflit d'intérêts

Conflict of interest statement The authors declare no conflict of interest.

Références

Lancet Infect Dis. 2015 Feb;15(2):212-24
pubmed: 25467650
Epidemiol Infect. 2017 Apr;145(5):857-863
pubmed: 28065212
Curr Infect Dis Rep. 2018 Jun 6;20(8):23
pubmed: 29876674
Infect Drug Resist. 2018 Nov 15;11:2321-2333
pubmed: 30532565
Ann Ig. 2017 Mar-Apr;29(2):101-115
pubmed: 28244579
Epidemiol Infect. 2016 Oct;144(13):2728-31
pubmed: 27586030
Commun Dis Public Health. 2000 Sep;3(3):163-7
pubmed: 11014026
Infect Control Hosp Epidemiol. 2019 Jun;40(6):621-626
pubmed: 30942147
J Hosp Infect. 2009 Aug;72(4):332-6
pubmed: 19278752

Auteurs

Gianluigi Quaranta (G)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Università Cattolica del Sacro Cuore, Roma, Italy.

Marcello DI Pumpo (M)

Università Cattolica del Sacro Cuore, Roma, Italy.

Daniele Ignazio LA Milia (DI)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.

Malgorzata Wachocka (M)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.

Fabio Pattavina (F)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.

Sara Vincenti (S)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.

Gianfranco Damiani (G)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Università Cattolica del Sacro Cuore, Roma, Italy.

Patrizia Laurenti (P)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Università Cattolica del Sacro Cuore, Roma, Italy.

Umberto Moscato (U)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Università Cattolica del Sacro Cuore, Roma, Italy.

Stefania Bruno (S)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.
Università Cattolica del Sacro Cuore, Roma, Italy.

Federica Boninti (F)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.

Federica Tuti (F)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.

Romina Sezzatini (R)

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH